Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Natco Pharma Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Scrutinizers Report along with voting results for the AGM held on 15th September, 2018 Proceedings of the 35th Annual General Meeting
Proceedings of the 35th Annual General Meeting Shareholder Meeting / Postal Ballot-Outcome of AGM
Outcome of the 35th Annual General Meeting held on 15 September,2018
Volume Shockers stock screener: Natco Pharma, Varun Beverages gain
Despite a weak market, some stocks are seeing momentum, moving up on high volumes. These include pharma companies, which are gaining as the rupee fall make products more competitive in the global market. Natco Pharma (which is in 13 stock screeners) is one such gainer. Natco Pharma has been a gainer on strong momentum in drug approvals by the FDA in the US market. Natco has built a strong portfolio of generics in the US and India, and in FY18, Natco's top four performers in the US have been the generic versions of Copaxone, Tamiflu, Doxorubicin and Lanthanum Carbonate. Copaxone should hold steady revenues for Natco in the coming quarters, as it is relatively difficult to copy. Also among the gainers are Shilpa Medicare, and pacgaking company Varun Beverages. For the full stock screener, click here. Natco Pharma: In fine fettle
Fresh approvals to market new generic formulations in the US and plans for a wider global footprint mean the firm is in the pink of health Read more Fixes Book Closure for AGM
Natco Pharma Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from September 12, 2018 to September 15, 2018 (both days inclusive) for the purpose of 35th Annual General Meeting (AGM) of the Company to be held on September 15, 2018. 35Th Annual General Meeting To Be Held On September 15, 2018
the 35th Annual General Meeting (AGM) of the Company will be held on Saturday, the 15th day of September, 2018 at 10.30 a.m. at Convention Centre, Hotel Daspalla, Road No.37, Jubilee Hills, Hyderabad 500 033. Natco Pharma partner files for doxorubicin hydrochloride injection in Europe
Hyderabad-based NATCO Pharma Ltd has announced that its co-development and marketing partner, Dr Reddy's Laboratories Ltd, has filed for doxorubicin Announcement under Regulation 30 (LODR)-Press Release / Media Release
Dr.Reddy's & NATCO file Doxorubicin Hydrochloride Liposome Injection in EUROPE